Literature DB >> 17161391

Developmental and injury-induced expression of alpha1beta1 and alpha6beta1 integrins in the rat spinal cord.

K Adam Baker1, Theo Hagg.   

Abstract

Loss and damage to blood vessels are thought to contribute to secondary tissue loss after spinal cord injury. Integrins might be therapeutic targets to protect the vasculature and/or promote angiogenesis, as their activation can promote tubule formation and survival of endothelial cells in vitro. Here, we show that immunostaining with an antibody against the alpha1beta1 integrin heterodimer is present only in blood vessels from postnatal day 1 (P1) through adulthood in Sprague-Dawley rats. After a spinal cord contusion at T9 in adults, the area of alpha1beta1 integrin positive blood vessels increases within 11 mm from the injury site at 3 days post-injury and remains prominent within the injured core only at 7 days. Staining for the alpha6beta1 integrin heterodimer increases in blood vessels between P10 and adulthood and is present in preganglionic neurons of the intermediolateral cell column (IML) at all ages. The alpha6beta1 integrin is also expressed by motor neurons postnatally, and oligodendrocyte precursors (OPCs), as previously reported. After the contusion, the area of alpha6beta1-stained blood vessels is increased at 3 days and most prominently, 1 mm from the injury site, followed by a significant reduction at 7 days, when alpha6beta1 integrin staining is most prominent around the injured core. Staining is also present in a subset of microglia and/or macrophages. These results raise the possibility that alpha1beta1 and alpha6beta1 integrins in blood vessels might be targeted to reduce blood vessel loss and promote angiogenesis, which may promote tissue sparing after spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17161391      PMCID: PMC1794000          DOI: 10.1016/j.brainres.2006.10.072

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  64 in total

1.  Correlative ultrastructural and immunohistochemical study of developing vascular basement membrane in postnatal rat spinal cord.

Authors:  J Rafałowska; A Fidziańska; D Dziewulska; A Podlecka; Z Jamrozik
Journal:  Pol J Pathol       Date:  2000       Impact factor: 1.072

2.  Regulation of laminin-associated integrin subunit mRNAs in rat spinal motoneurons during postnatal development and after axonal injury.

Authors:  H Hammarberg; W Wallquist; F Piehl; M Risling; S Cullheim
Journal:  J Comp Neurol       Date:  2000-12-11       Impact factor: 3.215

3.  New vascular tissue rapidly replaces neural parenchyma and vessels destroyed by a contusion injury to the rat spinal cord.

Authors:  Gizelda T B Casella; Alexander Marcillo; Mary Bartlett Bunge; Patrick M Wood
Journal:  Exp Neurol       Date:  2002-01       Impact factor: 5.330

Review 4.  The alpha(v)beta3 integrin, NF-kappaB, osteoprotegerin endothelial cell survival pathway. Potential role in angiogenesis.

Authors:  Marta Scatena; Cecilia Giachelli
Journal:  Trends Cardiovasc Med       Date:  2002-02       Impact factor: 6.677

Review 5.  Anoikis mechanisms.

Authors:  S M Frisch; R A Screaton
Journal:  Curr Opin Cell Biol       Date:  2001-10       Impact factor: 8.382

6.  Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization.

Authors:  A Pozzi; P E Moberg; L A Miles; S Wagner; P Soloway; H A Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

7.  The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis.

Authors:  Donald R Senger; Carole A Perruzzi; Michael Streit; Victor E Koteliansky; Antonin R de Fougerolles; Michael Detmar
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

8.  Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture.

Authors:  C U Kloss; M Bohatschek; G W Kreutzberg; G Raivich
Journal:  Exp Neurol       Date:  2001-03       Impact factor: 5.330

9.  The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans.

Authors:  Tatiana M Grzeszkiewicz; Volkhard Lindner; Ningyu Chen; Stephen C-T Lam; Lester F Lau
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

10.  Expression of s-laminin and laminin in the developing rat central nervous system.

Authors:  D D Hunter; R Llinas; M Ard; J P Merlie; J R Sanes
Journal:  J Comp Neurol       Date:  1992-09-08       Impact factor: 3.215

View more
  5 in total

1.  Vascular Pathology as a Potential Therapeutic Target in SCI.

Authors:  Richard L Benton; Theo Hagg
Journal:  Transl Stroke Res       Date:  2011-11-29       Impact factor: 6.829

Review 2.  Targeting microvasculature for neuroprotection after SCI.

Authors:  Janelle M Fassbender; Scott R Whittemore; Theo Hagg
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

3.  ADAM8 is selectively up-regulated in endothelial cells and is associated with angiogenesis after spinal cord injury in adult mice.

Authors:  Edward T Mahoney; Richard L Benton; Melissa A Maddie; Scott R Whittemore; Theo Hagg
Journal:  J Comp Neurol       Date:  2009-01-10       Impact factor: 3.215

4.  Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration.

Authors:  Melissa R Andrews; Stefan Czvitkovich; Elisa Dassie; Christina F Vogelaar; Andreas Faissner; Bas Blits; Fred H Gage; Charles ffrench-Constant; James W Fawcett
Journal:  J Neurosci       Date:  2009-04-29       Impact factor: 6.167

5.  Comparative analysis of the time-dependent functional and molecular changes in spinal cord degeneration induced by the G93A SOD1 gene mutation and by mechanical compression.

Authors:  Andrea Malaspina; Natasa Jokic; Wenlong L Huang; John V Priestley
Journal:  BMC Genomics       Date:  2008-10-23       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.